Parkinson?s Disease Therapeutics Market Size, Share 2024

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Parkinson

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson?s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Parkinson?s Disease Therapeutics Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Parkinson?s Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson?s Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson?s Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson?s Disease Therapeutics as of 2022)
Table 10. Global Market Parkinson?s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson?s Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Parkinson?s Disease Therapeutics Product Type
Table 13. Global Parkinson?s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson?s Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson?s Disease Therapeutics Market Challenges
Table 22. Global Parkinson?s Disease Therapeutics Sales by Type (K MT)
Table 23. Global Parkinson?s Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Parkinson?s Disease Therapeutics Sales (K MT) by Type (2019-2024)
Table 25. Global Parkinson?s Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson?s Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson?s Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Parkinson?s Disease Therapeutics Price (USD/MT) by Type (2019-2024)
Table 29. Global Parkinson?s Disease Therapeutics Sales (K MT) by Application
Table 30. Global Parkinson?s Disease Therapeutics Market Size by Application
Table 31. Global Parkinson?s Disease Therapeutics Sales by Application (2019-2024) & (K MT)
Table 32. Global Parkinson?s Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson?s Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson?s Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Parkinson?s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson?s Disease Therapeutics Sales by Region (2019-2024) & (K MT)
Table 37. Global Parkinson?s Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson?s Disease Therapeutics Sales by Country (2019-2024) & (K MT)
Table 39. Europe Parkinson?s Disease Therapeutics Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Parkinson?s Disease Therapeutics Sales by Region (2019-2024) & (K MT)
Table 41. South America Parkinson?s Disease Therapeutics Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Parkinson?s Disease Therapeutics Sales by Region (2019-2024) & (K MT)
Table 43. Global Parkinson?s Disease Therapeutics Production (K MT) by Region (2019-2024)
Table 44. Global Parkinson?s Disease Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Parkinson?s Disease Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Parkinson?s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Parkinson?s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Parkinson?s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Parkinson?s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Parkinson?s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Abbvie Parkinson?s Disease Therapeutics Basic Information
Table 52. Abbvie Parkinson?s Disease Therapeutics Product Overview
Table 53. Abbvie Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Abbvie Business Overview
Table 55. Abbvie Parkinson?s Disease Therapeutics SWOT Analysis
Table 56. Abbvie Recent Developments
Table 57. Biogen Parkinson?s Disease Therapeutics Basic Information
Table 58. Biogen Parkinson?s Disease Therapeutics Product Overview
Table 59. Biogen Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Biogen Business Overview
Table 61. Biogen Parkinson?s Disease Therapeutics SWOT Analysis
Table 62. Biogen Recent Developments
Table 63. Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Basic Information
Table 64. Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Product Overview
Table 65. Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics SWOT Analysis
Table 67. Boehringer Ingelheim GmbH Business Overview
Table 68. Boehringer Ingelheim GmbH Recent Developments
Table 69. F. Hoffman-La Roche Parkinson?s Disease Therapeutics Basic Information
Table 70. F. Hoffman-La Roche Parkinson?s Disease Therapeutics Product Overview
Table 71. F. Hoffman-La Roche Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. F. Hoffman-La Roche Business Overview
Table 73. F. Hoffman-La Roche Recent Developments
Table 74. GlaxoSmithKline Parkinson?s Disease Therapeutics Basic Information
Table 75. GlaxoSmithKline Parkinson?s Disease Therapeutics Product Overview
Table 76. GlaxoSmithKline Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Recent Developments
Table 79. H. Lundbeck A/S Parkinson?s Disease Therapeutics Basic Information
Table 80. H. Lundbeck A/S Parkinson?s Disease Therapeutics Product Overview
Table 81. H. Lundbeck A/S Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. H. Lundbeck A/S Business Overview
Table 83. H. Lundbeck A/S Recent Developments
Table 84. Impax Labs Parkinson?s Disease Therapeutics Basic Information
Table 85. Impax Labs Parkinson?s Disease Therapeutics Product Overview
Table 86. Impax Labs Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Impax Labs Business Overview
Table 88. Impax Labs Recent Developments
Table 89. Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Basic Information
Table 90. Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Product Overview
Table 91. Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Newron Pharmaceuticals SpA Business Overview
Table 93. Newron Pharmaceuticals SpA Recent Developments
Table 94. Novartis AG Parkinson?s Disease Therapeutics Basic Information
Table 95. Novartis AG Parkinson?s Disease Therapeutics Product Overview
Table 96. Novartis AG Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Recent Developments
Table 99. Orion Corporation Parkinson?s Disease Therapeutics Basic Information
Table 100. Orion Corporation Parkinson?s Disease Therapeutics Product Overview
Table 101. Orion Corporation Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Orion Corporation Business Overview
Table 103. Orion Corporation Recent Developments
Table 104. Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Basic Information
Table 105. Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Product Overview
Table 106. Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Teva Pharmaceutical Industries Ltd. Business Overview
Table 108. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 109. UCB S.A. Parkinson?s Disease Therapeutics Basic Information
Table 110. UCB S.A. Parkinson?s Disease Therapeutics Product Overview
Table 111. UCB S.A. Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. UCB S.A. Business Overview
Table 113. UCB S.A. Recent Developments
Table 114. Livzon Pharmaceutical Parkinson?s Disease Therapeutics Basic Information
Table 115. Livzon Pharmaceutical Parkinson?s Disease Therapeutics Product Overview
Table 116. Livzon Pharmaceutical Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Livzon Pharmaceutical Business Overview
Table 118. Livzon Pharmaceutical Recent Developments
Table 119. Haisco Pharmaceutical Parkinson?s Disease Therapeutics Basic Information
Table 120. Haisco Pharmaceutical Parkinson?s Disease Therapeutics Product Overview
Table 121. Haisco Pharmaceutical Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Haisco Pharmaceutical Business Overview
Table 123. Haisco Pharmaceutical Recent Developments
Table 124. Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Basic Information
Table 125. Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Product Overview
Table 126. Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Jingxin Pharmaceutical Business Overview
Table 128. Jingxin Pharmaceutical Recent Developments
Table 129. Dongcheng Biochemicals Parkinson?s Disease Therapeutics Basic Information
Table 130. Dongcheng Biochemicals Parkinson?s Disease Therapeutics Product Overview
Table 131. Dongcheng Biochemicals Parkinson?s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Dongcheng Biochemicals Business Overview
Table 133. Dongcheng Biochemicals Recent Developments
Table 134. Global Parkinson?s Disease Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 135. Global Parkinson?s Disease Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 136. North America Parkinson?s Disease Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 137. North America Parkinson?s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 138. Europe Parkinson?s Disease Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 139. Europe Parkinson?s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 140. Asia Pacific Parkinson?s Disease Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 141. Asia Pacific Parkinson?s Disease Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 142. South America Parkinson?s Disease Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 143. South America Parkinson?s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 144. Middle East and Africa Parkinson?s Disease Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 145. Middle East and Africa Parkinson?s Disease Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 146. Global Parkinson?s Disease Therapeutics Sales Forecast by Type (2025-2032) & (K MT)
Table 147. Global Parkinson?s Disease Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 148. Global Parkinson?s Disease Therapeutics Price Forecast by Type (2025-2032) & (USD/MT)
Table 149. Global Parkinson?s Disease Therapeutics Sales (K MT) Forecast by Application (2025-2032)
Table 150. Global Parkinson?s Disease Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Parkinson?s Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson?s Disease Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Parkinson?s Disease Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Parkinson?s Disease Therapeutics Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson?s Disease Therapeutics Market Size by Country (M USD)
Figure 11. Parkinson?s Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson?s Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Parkinson?s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson?s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson?s Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson?s Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Parkinson?s Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson?s Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Parkinson?s Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson?s Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson?s Disease Therapeutics Market Share by Application
Figure 24. Global Parkinson?s Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson?s Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Parkinson?s Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Parkinson?s Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Parkinson?s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson?s Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Parkinson?s Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Parkinson?s Disease Therapeutics Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson?s Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Parkinson?s Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Parkinson?s Disease Therapeutics Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Parkinson?s Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Parkinson?s Disease Therapeutics Sales and Growth Rate (K MT)
Figure 50. South America Parkinson?s Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Parkinson?s Disease Therapeutics Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Parkinson?s Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Parkinson?s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Parkinson?s Disease Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Parkinson?s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Parkinson?s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Parkinson?s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 65. China Parkinson?s Disease Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Parkinson?s Disease Therapeutics Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Parkinson?s Disease Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Parkinson?s Disease Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Parkinson?s Disease Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Parkinson?s Disease Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Parkinson?s Disease Therapeutics Market Share Forecast by Application (2025-2032)

DOWNLOAD SAMPLE